New Edge Advisors, LLC Alkermes Plc. Transaction History
New Edge Advisors, LLC
- $16 Billion
- Q4 2024
A detailed history of New Edge Advisors, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 158 shares of ALKS stock, worth $5,425. This represents 0.0% of its overall portfolio holdings.
Number of Shares
158
Previous 57
177.19%
Holding current value
$5,425
Previous $1,000
300.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ALKS
# of Institutions
376Shares Held
173MCall Options Held
231KPut Options Held
158K-
Black Rock Inc. New York, NY29.1MShares$1 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$635 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$421 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$303 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$260 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.64B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...